Literature DB >> 1003061

Interactions of oestradiol-17beta and tamoxifen in the uterus of the pregnant rat.

J S Major, B Green, P J Heald.   

Abstract

Measurement of the uptake and retention of a radioactive post-coital antifertility agent tamioxifen, by reproductive tissues of the rat have shown that the ovary retained more radioactivity than did any other reproductive organ. Studies have also been made of the uptake and distribution of [3H]tamoxifen and [3H]oestradiol-17beta in the uterus of the pregnant rat on days 2-6 post coitum. Twenty-four hours after administration of tamoxifen, either i.v. or orally, 40-50% of the radioactivity was in the high speed pellet, 10-20% in the nuclear fraction, and 15-30% in the cytosol. An equivalent dose of [3H]oestradiol-17beta yielded distributions of 5%, 5% and 82% respectively. Fractionation of uteri from animals given 0-2 mg tamoxifen/kg on Day 2 of pregnancy followed by [3H]oestradiol 60 min before death showed little difference in total uptake of oestradiol or distribution in the subcellular fraction on Days 4,5 and 6. Although uptake of oestradiol by uterine nuclei was reduced on Day 3 by previous administration of tamoxifen on Day 2, appreciable quantities were still bound to the nuclear receptors. Treatment of ovariectomized animals with tamoxifen at doses up to 40 mug/rat (i.e. 0-2 mg/kg) led to the accumulation of oestrogen-receptor complex in the nucleus. It is concluded that the antifertility properties of tamoxifen (under the conditions of these experiments) cannot be ascribed to the suppression of uptake and binding of oestradiol by the uterus.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1003061     DOI: 10.1677/joe.0.0710315

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  4 in total

Review 1.  Clinical pharmacokinetics of endocrine agents used in advanced breast cancer.

Authors:  P E Lønning; E A Lien; S Lundgren; S Kvinnsland
Journal:  Clin Pharmacokinet       Date:  1992-05       Impact factor: 6.447

2.  Differential depletion of cytoplasmic high affinity oestrogen receptors after the in vivo administration of the antioestrogens, clomiphene, MER-25 and tamoxifen.

Authors:  R N Kurl; I D Morris
Journal:  Br J Pharmacol       Date:  1978-04       Impact factor: 8.739

Review 3.  Tamoxifen: a review of its pharmacological properties and therapeutic use in the treatment of breast cancer.

Authors:  R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1978-07       Impact factor: 9.546

4.  Pharmacokinetics of droloxifene in mice, rats, monkeys, premenopausal and postmenopausal patients.

Authors:  Y Tanaka; M Sekiguchi; T Sawamoto; T Hata; Y Esumi; S Sugai; S Ninomiya
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1994 Jan-Mar       Impact factor: 2.441

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.